Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 9.152 Q1 | 254 | 26 | 105 | 12841 | 2372 | 105 | 19.35 | 493.88 | |
2 | Pharmacology and Therapeutics | journal | 4.048 Q1 | 233 | 107 | 314 | 21251 | 3282 | 313 | 11.04 | 198.61 | |
3 | Medicinal Research Reviews | journal | 2.534 Q1 | 150 | 39 | 97 | 6938 | 826 | 96 | 8.89 | 177.90 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.812 Q1 | 70 | 8 | 15 | 1415 | 101 | 15 | 6.73 | 176.88 | |
5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.137 Q1 | 82 | 15 | 38 | 2511 | 166 | 38 | 5.15 | 167.40 | |
6 | Advances in Molecular Toxicology | book series | 0.334 Q3 | 18 | 7 | 22 | 1014 | 32 | 0 | 1.00 | 144.86 | |
7 | Perspectives in Medicinal Chemistry | journal | 0.108 Q4 | 17 | 5 | 2 | 700 | 0 | 2 | 0.00 | 140.00 | |
8 | Advances in Pharmacology | journal | 2.233 Q1 | 86 | 46 | 104 | 6266 | 512 | 0 | 4.61 | 136.22 | |
9 | Current Neuropharmacology | journal | 1.212 Q1 | 103 | 44 | 177 | 5733 | 573 | 168 | 3.30 | 130.30 | |
10 | Annual Review of Pharmacology and Toxicology | journal | 9.351 Q1 | 224 | 27 | 71 | 3483 | 1457 | 70 | 20.74 | 129.00 | |
11 | Journal of Receptor, Ligand and Channel Research | journal | 0.195 Q3 | 13 | 9 | 9 | 1155 | 6 | 8 | 0.75 | 128.33 | |
12 | Current Drug Metabolism | journal | 1.014 Q2 | 122 | 70 | 329 | 8760 | 1127 | 291 | 3.23 | 125.14 | |
13 | Current Medicinal Chemistry | journal | 1.282 Q1 | 202 | 322 | 1293 | 39596 | 5384 | 1224 | 4.11 | 122.97 | |
14 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 | |
15 | Cellular and Molecular Life Sciences | journal | 3.454 Q1 | 261 | 311 | 891 | 35012 | 5773 | 885 | 6.10 | 112.58 | |
16 | Current Drug Targets | journal | 1.395 Q1 | 119 | 118 | 561 | 12855 | 1973 | 508 | 3.19 | 108.94 | |
17 | Progress in Medicinal Chemistry | journal | 1.293 Q1 | 38 | 5 | 17 | 534 | 61 | 1 | 3.27 | 106.80 | |
18 | Cancer Therapy | journal | 0.221 Q3 | 9 | 4 | 14 | 408 | 19 | 14 | 0.18 | 102.00 | |
19 | Drug Resistance Updates | journal | 3.578 Q1 | 132 | 9 | 63 | 904 | 687 | 59 | 10.06 | 100.44 | |
20 | Expert Opinion on Therapeutic Targets | journal | 1.990 Q1 | 106 | 116 | 380 | 11340 | 1797 | 367 | 4.78 | 97.76 | |
21 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | |
22 | Current Cancer Drug Targets | journal | 1.533 Q1 | 103 | 65 | 265 | 6080 | 1029 | 246 | 3.86 | 93.54 | |
23 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 127 | 375 | 11853 | 1234 | 373 | 3.30 | 93.33 | |
24 | CNS and Neurological Disorders - Drug Targets | journal | 1.070 Q1 | 96 | 196 | 362 | 18231 | 990 | 313 | 2.50 | 93.02 | |
25 | Neurotherapeutics | journal | 2.433 Q1 | 136 | 79 | 206 | 7345 | 1133 | 193 | 5.41 | 92.97 | |
26 | Mini-Reviews in Medicinal Chemistry | journal | 0.769 Q2 | 107 | 95 | 412 | 8756 | 1381 | 393 | 3.20 | 92.17 | |
27 | Current Molecular Pharmacology | journal | 1.419 Q1 | 49 | 18 | 77 | 1656 | 261 | 69 | 2.78 | 92.00 | |
28 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 108 | 105 | 9908 | 3 | 6 | 0.04 | 91.74 | |
29 | Current Vascular Pharmacology | journal | 0.828 Q2 | 69 | 109 | 275 | 9714 | 772 | 247 | 2.46 | 89.12 | |
30 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.172 Q4 | 29 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | |
31 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | |
32 | Clinical Medicine Insights: Therapeutics | journal | 0.152 Q4 | 11 | 4 | 79 | 348 | 27 | 79 | 0.49 | 87.00 | |
33 | Vaccines | journal | 0.123 Q4 | 85 | 42 | 2 | 3639 | 0 | 1 | 0.00 | 86.64 | |
34 | Issues in Toxicology | book series | 0.164 Q4 | 18 | 54 | 126 | 4628 | 34 | 116 | 0.29 | 85.70 | |
35 | Expert Opinion on Therapeutic Patents | journal | 1.310 Q1 | 88 | 102 | 324 | 8692 | 1270 | 323 | 4.42 | 85.22 | |
36 | Expert Opinion on Investigational Drugs | journal | 1.431 Q1 | 117 | 140 | 442 | 11529 | 1741 | 434 | 4.18 | 82.35 | |
37 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.963 Q2 | 108 | 144 | 409 | 11251 | 1144 | 375 | 2.65 | 78.13 | |
38 | Neuropharmacology | journal | 2.410 Q1 | 191 | 423 | 1166 | 32705 | 6304 | 1145 | 5.65 | 77.32 | |
39 | Frontiers in Pharmacology | journal | 1.560 Q1 | 154 | 272 | 444 | 20945 | 1872 | 425 | 4.14 | 77.00 | |
40 | Inflammation and Allergy - Drug Targets | journal | 0.814 Q2 | 55 | 43 | 178 | 3300 | 417 | 163 | 2.14 | 76.74 | |
41 | British Journal of Pharmacology | journal | 2.202 Q1 | 244 | 425 | 1453 | 32394 | 7579 | 1413 | 5.08 | 76.22 | |
42 | Pharmacological Research | journal | 2.031 Q1 | 169 | 106 | 428 | 7971 | 2258 | 416 | 5.49 | 75.20 | |
43 | Trends in Pharmacological Sciences | journal | 5.062 Q1 | 244 | 83 | 268 | 6223 | 2661 | 236 | 10.22 | 74.98 | |
44 | Journal of NeuroImmune Pharmacology | journal | 1.587 Q1 | 91 | 58 | 266 | 4312 | 947 | 255 | 4.09 | 74.34 | |
45 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.652 Q2 | 88 | 38 | 145 | 2768 | 369 | 145 | 2.30 | 72.84 | |
46 | Pharmacognosy Reviews (discontinued) | journal | 0.817 Q2 | 68 | 19 | 69 | 1377 | 210 | 68 | 1.89 | 72.47 | |
47 | Expert Opinion on Biological Therapy | journal | 1.326 Q1 | 102 | 162 | 487 | 11723 | 1875 | 476 | 3.97 | 72.36 | |
48 | Pharmacogenomics and Personalized Medicine | journal | 0.901 Q2 | 37 | 36 | 38 | 2605 | 124 | 38 | 3.41 | 72.36 | |
49 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.789 Q1 | 150 | 187 | 723 | 13392 | 3205 | 677 | 4.22 | 71.61 | |
50 | Behavioural Pharmacology | journal | 1.051 Q2 | 87 | 77 | 262 | 5435 | 668 | 259 | 2.58 | 70.58 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®